Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-02-25 @ 5:52 PM
Study NCT ID:
NCT02911857
Status:
COMPLETED
Last Update Posted:
2018-08-20
First Post:
2016-09-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Periodic Fevers Syndrome | View |